文献速递肝病

长链非编码RNA H19在多药耐药2基因敲除小鼠胆汁淤积性肝损伤性别差异中的作用

The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
PubMed 文献 · Hepatology · 2017-07-20

多药耐药2基因敲除(Mdr2-/-)小鼠是胆汁淤积性胆管病模型,雌性比雄性肝损伤更重且胆汁中牛磺胆酸盐比例更高。研究发现H19在100日龄雌性Mdr2-/-小鼠肝脏中诱导约200倍,主要表达于胆管细胞;敲低H19可减轻雌性小鼠胆汁淤积性损伤,人原发性硬化性胆管炎肝样本有类似发现。

要点

  • H19在晚期(100日龄)雌性Mdr2-/-小鼠肝脏诱导约200倍,雄性及早期阶段表达极低。
  • H19主要表达于胆管细胞,牛磺胆酸盐和雌激素激活ERK1/2并诱导其表达。
  • 敲低H19可减少纤维化基因和S1PR2表达,并显著减轻雌性小鼠胆汁淤积性损伤。

核心结论

  • H19在胆汁淤积疾病进展中起关键作用,是导致Mdr2-/-小鼠胆汁淤积性肝损伤性别差异的关键因素。

研究设计与样本

  • 研究使用多药耐药2基因敲除(Mdr2-/-)小鼠模型,比较雌雄小鼠在胆汁淤积早期与晚期(100日龄)的肝脏H19表达。
  • 在胆管细胞中检测牛磺胆酸盐和雌激素对细胞外信号调节激酶1/2信号通路及H19表达的激活作用。
  • 通过敲低H19评估其对纤维化基因、鞘氨醇1-磷酸受体2表达及雌性Mdr2-/-小鼠胆汁淤积性损伤的影响。
  • 在人原发性硬化性胆管炎肝样本中验证类似发现。

主要发现

  • H19在100日龄雌性Mdr2-/-小鼠肝脏中诱导约200倍,而年龄匹配的雄性小鼠及胆汁淤积早期阶段表达极低。
  • 肝脏H19主要表达于胆管细胞而非肝细胞。
  • 牛磺胆酸盐和雌激素均显著激活细胞外信号调节激酶1/2通路并诱导胆管细胞H19表达。
  • 敲低H19不仅显著减少牛磺胆酸盐/雌激素诱导的纤维化基因和鞘氨醇1-磷酸受体2表达,还显著减轻雌性Mdr2-/-小鼠的胆汁淤积性损伤。
  • 晚期肝纤维化阶段小异二聚体伴侣表达受抑,雌性Mdr2-/-小鼠中H19短发夹RNA可逆转该抑制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The multidrug resistance 2 knockout (Mdr2-/- ) mouse is a well-established model of cholestatic cholangiopathies. Female Mdr2-/- mice develop more severe hepatobiliary damage than male Mdr2-/- mice, which is correlated with a higher proportion of taurocholate in the bile. Although estrogen has been identified as an important player in intrahepatic cholestasis, the underlying molecular mechanisms of gender-based disparity of cholestatic injury remain unclear. The long noncoding RNA H19 is an imprinted, maternally expressed, and estrogen-targeted gene, which is significantly induced in human fibrotic/cirrhotic liver and bile duct-ligated mouse liver. However, whether aberrant expression of H19 accounts for gender-based disparity of cholestatic injury in Mdr2-/- mice remains unknown. The current study demonstrated that H19 was markedly induced (∼200-fold) in the livers of female Mdr2-/- mice at advanced stages of cholestasis (100 days old) but not in age-matched male Mdr2-/- mice. During the early stages of cholestasis, H19 expression was minimal. We further determined that hepatic H19 was mainly expressed in cholangiocytes, not hepatocytes. Both taurocholate and estrogen significantly activated the extracellular signal-regulated kinase 1/2 signaling pathway and induced H19 expression in cholangiocytes. Knocking down H19 not only significantly reduced taurocholate/estrogen-induced expression of fibrotic genes and sphingosine 1-phosphate receptor 2 in cholangiocytes but also markedly reduced cholestatic injury in female Mdr2-/- mice. Furthermore, expression of small heterodimer partner was substantially inhibited at advanced stages of liver fibrosis, which was reversed by H19 short hairpin RNA in female Mdr2-/- mice. Similar findings were obtained in human primary sclerosing cholangitis liver samples. CONCLUSION: H19 plays a critical role in the disease progression of cholestasis and represents a key factor that causes the gender disparity of cholestatic liver injury in Mdr2-/- mice. (Hepatology 2017;66:869-884).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Li X, Liu R, Yang J, et al. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice. Hepatology. 2017. PMID: 28271527. doi:10.1002/hep.29145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。